Details

Last Funding Type

Grant

Last Funding Money Raised

$5.60M

Industries

Biopharma,Biotechnology,Health Care,Medical

Founded date

Jan 1, 2015

Number Of Employee

51 - 100

Operating Status

Active

Aptinyx Inc. is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication. This mechanism has applicability across a number of CNS disorders. Our goal is to rapidly advance our most promising drug candidates into clinical development for indications with high unmet medical need.